Testing effectiveness (Phase 2)WithdrawnNCT04358471
What this trial is testing
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyGene Therapy+1 more
Hemera Biosciences